MIR3177

Across TCGA pan-cancer cohorts, MIR3177 RNA is linked to patient survival in 14 of 34 cancer types, making it the most broadly survival-associated MIR3177 data layer.

The strongest signal is observed in mesothelioma (MESO), where higher MIR3177 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated MIR3177 expression acts as an unfavorable survival marker, although some lineages such as KIRC and ACC show a favorable association.

MESO, UVM, and CHOL are the cancer types where MIR3177 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
MESO	OS	Tertile	III,IV	0.302	0.612	.003	108	view →
UVM	OS	Tertile	III,IV	0.241	0.765	.002	54	view →
CHOL	DFS	Tertile	II,III,IV	0.049	0.430	.014	45	view →
STAD	DFS	Quartile	III,IV	0.337	0.582	.002	29	view →
KIRC	DFS	Tertile	II,III,IV	0.892	0.741	.003	22	view →
LUSC	OS	Tertile	IV	0.001	0.651	.025	20	view →
LIHC	DFS	Tertile	All	0.291	0.549	.019	12	view →
UCEC	OS	Tertile	III,IV	0.705	0.846	.029	12	view →
COAD	DFS	Tertile	All	0.729	0.800	.015	11	view →
ACC	OS	Tertile	III,IV	0.919	0.456	.024	6	view →
ESCA	OS	Tertile	IV	0.243	0.738	.024	6	view →
BLCA	OS	Quartile	III,IV	0.448	0.601	.023	3	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 14 lineages.

MIR3177–MESO (OS)

Open the MESO breakdown →